Ethical, Legal, & Social Implications: Real-World Data Generation & Sharing in 21st Century Medicine

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the ethical and policy challenges of using real-world data in medicine. The argumentation is solid, grounded in the speaker’s research and regulatory frameworks. The speaker effectively uses survey data to illustrate public attitudes, though the findings are from a single study and may not be generalizable. The discussion of informed consent and synthetic data highlights important ethical considerations, but the presentation is more descriptive than prescriptive, leaving room for further debate.

Scientific Rigor, Source Quality, Title Accuracy

The speaker demonstrates scientific rigor by referencing FDA definitions, the 21st Century Cures Act, and her own published research. The sources cited are credible, though the presentation relies heavily on the speaker’s own work. The title accurately reflects the content, which is well-organized and comprehensive. The seminar is suitable for an academic audience, but the lack of external sources and the speaker’s dual role as researcher and presenter may introduce bias.

The title accurately reflects the content, which covers ethical, legal, and social implications of real-world data generation and sharing in medicine.

8/10

Presentation by a recognized expert in health policy and bioethics, grounded in peer-reviewed research and regulatory frameworks. The content is well-structured and evidence-based, though it reflects the author's perspective and does not include external verification.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and overview of the seminar topics
• 05:00Definition of real-world data and real-world evidence
• 10:00Discussion on the medical product development pipeline and role of RWE
• 15:00Survey findings on willingness to share real-world data
• 20:00Post-mortem data sharing preferences
• 25:00Informed consent challenges in point-of-care trials
• 30:00Synthetic data generation using generative AI
• 35:00Ethical considerations and discussion on health system trustworthiness

• Health Affairs Forefront article on health system trustworthiness — Referenced as a piece published by the speaker in January 2024 outlining actions for health systems to achieve trustworthiness.
• FDA definition of real-world data — Used to define real-world data and real-world evidence.
• 21st Century Cures Act — Mentioned as the legislative act that spurred innovation in real-world data and genomics.
• ResearchMatch registry — Used as the recruitment platform for the survey on data sharing willingness.

• FDA Real-World Evidence Program — Aligns with the speaker's use of FDA definitions and the role of RWE in regulatory decisions.
• ResearchMatch — The registry used for the survey, supporting the methodology.